These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 33005040)

  • 1. Complement in neurological disorders and emerging complement-targeted therapeutics.
    Dalakas MC; Alexopoulos H; Spaeth PJ
    Nat Rev Neurol; 2020 Nov; 16(11):601-617. PubMed ID: 33005040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement-Mediated Microglial Phagocytosis and Pathological Changes in the Development and Degeneration of the Visual System.
    Borucki DM; Toutonji A; Couch C; Mallah K; Rohrer B; Tomlinson S
    Front Immunol; 2020; 11():566892. PubMed ID: 33072106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant Complement System Activation in Neurological Disorders.
    Ziabska K; Ziemka-Nalecz M; Pawelec P; Sypecka J; Zalewska T
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
    Levite M
    J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emerging role of complement in neuromuscular disorders.
    Lee JD; Woodruff TM
    Semin Immunopathol; 2021 Dec; 43(6):817-828. PubMed ID: 34705082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic targeting of complement to modify disease course and improve outcomes in neurological conditions.
    Brennan FH; Lee JD; Ruitenberg MJ; Woodruff TM
    Semin Immunol; 2016 Jun; 28(3):292-308. PubMed ID: 27049459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement system and the brain: selected pathologies and avenues toward engineering of neurological nanomedicines.
    Lettiero B; Andersen AJ; Hunter AC; Moghimi SM
    J Control Release; 2012 Jul; 161(2):283-9. PubMed ID: 22094105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A targeted complement-dependent strategy to improve the outcome of mAb therapy, and characterization in a murine model of metastatic cancer.
    Elvington M; Huang Y; Morgan BP; Qiao F; van Rooijen N; Atkinson C; Tomlinson S
    Blood; 2012 Jun; 119(25):6043-51. PubMed ID: 22442351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of host cells by complement regulators.
    Schmidt CQ; Lambris JD; Ricklin D
    Immunol Rev; 2016 Nov; 274(1):152-171. PubMed ID: 27782321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of complement and potential of complement inhibitors in myasthenia gravis and neuromyelitis optica spectrum disorders: a brief review.
    Chamberlain JL; Huda S; Whittam DH; Matiello M; Morgan BP; Jacob A
    J Neurol; 2021 May; 268(5):1643-1664. PubMed ID: 31482201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myasthenia gravis: the role of complement at the neuromuscular junction.
    Howard JF
    Ann N Y Acad Sci; 2018 Jan; 1412(1):113-128. PubMed ID: 29266249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement and autoimmunity.
    Ballanti E; Perricone C; Greco E; Ballanti M; Di Muzio G; Chimenti MS; Perricone R
    Immunol Res; 2013 Jul; 56(2-3):477-91. PubMed ID: 23615835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of complement systems in IVIG mediated attenuation of cognitive deterioration in Alzheimer's disease.
    Gong B; Levine S; Barnum SR; Pasinetti GM
    Curr Alzheimer Res; 2014; 11(7):637-44. PubMed ID: 25115545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of complement and perspectives for intervention in transplantation.
    Chen G; Chen S; Chen X
    Immunobiology; 2013 May; 218(5):817-27. PubMed ID: 23182708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is complement good or bad for cancer patients? A new perspective on an old dilemma.
    Markiewski MM; Lambris JD
    Trends Immunol; 2009 Jun; 30(6):286-92. PubMed ID: 19428302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent developments in low molecular weight complement inhibitors.
    Qu H; Ricklin D; Lambris JD
    Mol Immunol; 2009 Dec; 47(2-3):185-95. PubMed ID: 19800693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy for neurological diseases.
    Villoslada P; Moreno B; Melero I; Pablos JL; Martino G; Uccelli A; Montalban X; Avila J; Rivest S; Acarin L; Appel S; Khoury SJ; McGeer P; Ferrer I; Delgado M; Obeso J; Schwartz M
    Clin Immunol; 2008 Sep; 128(3):294-305. PubMed ID: 18534912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Immunopathology of Complement Proteins and Innate Immunity in Autoimmune Disease.
    Defendi F; Thielens NM; Clavarino G; Cesbron JY; Dumestre-Pérard C
    Clin Rev Allergy Immunol; 2020 Apr; 58(2):229-251. PubMed ID: 31834594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precision Medicine in Neurology: The Inspirational Paradigm of Complement Therapeutics.
    Gavriilaki M; Kimiskidis VK; Gavriilaki E
    Pharmaceuticals (Basel); 2020 Oct; 13(11):. PubMed ID: 33114553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined use of plasma exchange and intravenous immunoglobulins.
    Nydegger UE; Rieben R
    Ann Med Interne (Paris); 1994; 145(5):287-92. PubMed ID: 7985933
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 31.